Bristol-Myers Squibb Articles
B-MS names Jean-Marc Huet as SVP and CFO
10 March 2008
CHMP approves new 300mg loading dose tablet of Plavix
10 March 2008
Pharmacopeia intitiates Ph IIb trial of DARA drug
10 March 2008
FDA clears Abilify in pediatric bipolar patients
10 March 2008
AstraZeneca to appeal $215M Ala damages
3 March 2008
Doctors claim statins cause memory loss
25 February 2008
Executive changes at B-MS
18 February 2008
APP gets US approval for generic Cafcit
18 February 2008
UK's NICE asked to develop new clinical health guidance for DoH
18 February 2008
B-MS' Reyataz/r non-inferior to lopinavir/r
18 February 2008
ImClone's 4th-qtr hurt by $60M settlement
14 February 2008
MI risk in ACS doubles after Plavix stopped
14 February 2008
Plavix rebound cuts B-MS' 4th-qtr 2007 loss and offsets $797M charge
11 February 2008
wt-KRAS as Erbitux efficacy biomarker
4 February 2008
Cogentus initiates Ph III CGT-2168 trial
28 January 2008
Final FDA appro for Caraco's generic Metaglip
21 January 2008
Meta-analysis in The Lancet recommends statins for all diabetics, regardless of CV risk
21 January 2008
Christian Deleuze and Michael Seeley join LEEM
14 January 2008
Bristol-Myers Squibb sells medical imaging unit for $525M
7 January 2008
Stock Commentary - New York week to January 7, 2008
7 January 2008
EC approves B-MS/Gilead's Atripla
24 December 2007
HIV/AIDS drug Atripla debuts in UK
24 December 2007
Mixed late-stage data on B-MS/Medarex' ipilimumab
17 December 2007
Stock Commentary - New York week to Dec 10, 2007
17 December 2007
3rd-qtr global pharmaceutical R&D pipeline report from Fitch
17 December 2007
ImClone/Sanofi sign $120M Yeda settlement
17 December 2007
B-MS to cut 10% of workforce in a bid to save $1.5B in time for loss of Plavix patent
17 December 2007
UPDATE: Indonesia considers three more CLs
10 December 2007
Raft of pending patent expiries threaten cardiovascular blockbusters
10 December 2007
Indonesia considers three more CLs
10 December 2007
B-MS halts vinflunine deal with Fabre
3 December 2007
FDA clears Abilify as add-on to antidepressants in adults with MDD
26 November 2007
FDA clears Avalide as initial high BP therapy
26 November 2007
FDA grants Abilify priority review status
26 November 2007
Drug sales up 5% in year to September 2007
26 November 2007
B-MS' suppresses HBV load at 192 weeks
21 November 2007
Lilly/Daiichi Sankyo's prasugrel cuts CV AEs 19% vs Plavix, but side effects raise doubts
21 November 2007
Strong long-term efficacy and safety data for Orencia
19 November 2007
Thailand protests over drug supply reform
19 November 2007
FDA clear Abilify for adolescents
12 November 2007
CHMP recommends approval of Atripla for HIV-1
29 October 2007
Pharmacopeia acquires B-MS' SARM program
22 October 2007
Atripla approved in Canada for HIV-1
22 October 2007
Sanofi-Aventis chief calls for volume pricing
22 October 2007
FDA OKs Ixempra for breast cancer
22 October 2007
Erbitux partners plan for Japan marketing
22 October 2007
Drug sales up 5% in year to August 2007
22 October 2007
Statins provide benefits after use stopped
22 October 2007
Jeremy Levin joins B-MS' R&D division
8 October 2007
FDA clears update to Erbitux labeling
8 October 2007
14th annual ECCO conference hears exciting data on combination therapy with biologics
8 October 2007
UPDATE: China's fake Rx drug factories exposed, imitation Viagra "would give overdose"
1 October 2007
Patent expiries will reduce bipolar drug market $400M
1 October 2007
B-MS in agreed deal to buy Adnexus for $430M
1 October 2007
FDA OK 300mg loading dose of Sanofi's Plavix
27 September 2007
First pediatric HIV/AIDS center in West Africa under construction
27 September 2007
US pharmacists oppose new Medicaid Rx rule
24 September 2007
Pharma industry's first joint center for pharmacovigilance in India
24 September 2007
Pharma industry's first joint center for pharmacovigilance in India
24 September 2007
AHF blames drug firms for slow ARV uptake
24 September 2007
Drug sales up 5% in year to July 2007
24 September 2007
Stock Commentary - New York week to Sept 10, 2007
17 September 2007
World Conference on Lung Cancer highlights important developments
17 September 2007
Business spending on R&D in Australia soars to record A$10.1 billion, boosted by pharma
10 September 2007
Pfizer and B-MS finalize DGAT-1 collaboration
3 September 2007
Spectrum gets world rights to ortataxel
20 August 2007
US FDA accepts sBLA for B-MS' Orencia
13 August 2007
ImClone's 2nd-qtr profit drops 14% to $319M
13 August 2007
Cancer Research UK Oks Champix approval
6 August 2007
ImClone and B-MS amend Erbitux deal
6 August 2007
GPC Biotech named in US class action
6 August 2007
Truvada/Sustiva cuts viral load vs Combivir/Sustiva
6 August 2007
Encouraging data for GSK's Lexiva
6 August 2007
FDA marks Abilify sNDA for priority review
30 July 2007
Stock Commentary - New York - week to July 16, 2007
23 July 2007
Pfizer
23 July 2007
B-MS/Pfizer anti-clotting drug shows promise
16 July 2007
Medivir and B-MS end HIV drug accord
16 July 2007
B-MS sells analgesics to Lion for $250M
9 July 2007
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
